Rimonabant

Definition: Rimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious psychiatric side effects; it was never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid receptor CB1 and was first-in-class for clinical development. source: Wikipedia

ID

422794008

ID date

29 Jun 2007

Previous ID

10608211000001107

Name

Rimonabant